VIBHUTIBEN PATEL: Open Payments
NPI 1417717752 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 33 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $240 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $175 |
| Exact Sciences Corporation | 2 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| Novo Nordisk Inc | 2 | $44 |
| ABBVIE INC. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: CAPLYTA, OTEZLA, Cologuard Collection Kit, XIFAXAN, REPATHA, Ozempic, VRAYLAR, INJECTAFER.
Industry payments across NV — which companies pay providers there.
